雅培推出：新一代心脏瓣膜修复系统

器械之家08-10

器械之家医疗器械媒体报道先锋分享专业医疗器械知识关注来源：Medtech Dive 医潜，未经授权不得转载，且24小时后方可转载。2025年8月6日，雅培（纽约证券交易所代码：ABT）宣布，其最新一代MitraClip和TriClip G5系统正式上市。这两款经导管瓣膜修复装置旨在为二尖瓣反流（MR）和三尖瓣反流（TR）患者提供更安全、精准的治疗选择，标志着结构性心脏病介入治疗领域的技术突破。雅培...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2558862776?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-10 18:47","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2558862776","market":"us","top_or_hot":-1,"title":"雅培推出：新一代心脏瓣膜修复系统","media":"器械之家","content":"<div>\n<p>器械之家医疗器械媒体报道先锋分享专业医疗器械知识关注来源：Medtech Dive 医潜，未经授权不得转载，且24小时后方可转载。2025年8月6日，雅培（纽约证券交易所代码：ABT）宣布，其最新一代MitraClip和TriClip G5系统正式上市。这两款经导管瓣膜修复装置旨在为二尖瓣反流（MR）和三尖瓣反流（TR）患者提供更安全、精准的治疗选择，标志着结构性心脏病介入治疗领域的技术突破。雅培...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810185207a6ddb33e&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>雅培推出：新一代心脏瓣膜修复系统</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n雅培推出：新一代心脏瓣膜修复系统\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-10 18:47 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810185207a6ddb33e&s=b><strong>器械之家</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>器械之家医疗器械媒体报道先锋分享专业医疗器械知识关注来源：Medtech Dive 医潜，未经授权不得转载，且24小时后方可转载。2025年8月6日，雅培（纽约证券交易所代码：ABT）宣布，其最新一代MitraClip和TriClip G5系统正式上市。这两款经导管瓣膜修复装置旨在为二尖瓣反流（MR）和三尖瓣反流（TR）患者提供更安全、精准的治疗选择，标志着结构性心脏病介入治疗领域的技术突破。雅培...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810185207a6ddb33e&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ABT","symbol_name":"雅培","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810185207a6ddb33e&s=b","article_id":"2558862776","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250810185207a6ddb33e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2558862776","pubTimestamp":1754822878,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"2025年8月6日，雅培宣布，其最新一代MitraClip和TriClip G5系统正式上市。雅培在心夹植入物中采用镍钛诺合金，其超弹性特性确保器械在复杂心脏解剖结构中稳定夹持瓣膜，同时减少组织损伤风险。随着人口老龄化加剧，结构性心脏病发病率持续上升，微创介入技术已成为治疗趋势。雅培新一代MitraClip和TriClip G5系统的上市，不仅为临床提供了更高效的工具，也通过医保覆盖政策扩大了患者可及性。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ABT":"雅培","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU1721429741.USD":"BNP PARIBAS SMART FOOD \"CRH\" (USD) INC","LU1721429402.USD":"BNP PARIBAS SMART FOOD \"C\" (USD) ACC","BK4581":"高盛持仓","LU0234572021.USD":"高盛美国核心股票组合Acc","LU0122379950.USD":"贝莱德世界健康科学A2","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","BK4585":"ETF&股票定投概念","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","BK4566":"资本集团","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","BK4082":"医疗保健设备","BK4592":"伊斯兰概念","SG9999002232.USD":"Allianz Global High Payout USD","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","BK4504":"桥水持仓","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU1989763690.USD":"东方汇理世代食品基金A2 Acc","SG9999002224.SGD":"Allianz Global High Payout SGD","BK4588":"碎股","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","BK4568":"美国抗疫概念","LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","LU1989763427.SGD":"CPR Invest - Food For Generations A2 Acc SGD-H","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU2211815571.USD":"ALLIANZ POSITIVE CHANGE \"AT\" (USD) ACC"},"translate_title":"Abbott launches: new generation heart valve repair system","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABT":1},"content_text":"器械之家医疗器械媒体报道先锋分享专业医疗器械知识关注来源：Medtech Dive 医潜，未经授权不得转载，且24小时后方可转载。2025年8月6日，雅培（纽约证券交易所代码：ABT）宣布，其最新一代MitraClip和TriClip G5系统正式上市。这两款经导管瓣膜修复装置旨在为二尖瓣反流（MR）和三尖瓣反流（TR）患者提供更安全、精准的治疗选择，标志着结构性心脏病介入治疗领域的技术突破。雅培结构心脏部门高级副总裁Sandra Lesenfants在LinkedIn官方声明中表示：“G5系统是团队无数小时研发、临床对话与不懈努力的结晶。我们始终致力于通过创新解决方案满足医生和患者的需求，新一代产品正是这一承诺的体现。”据公司介绍，MitraClip G5和TriClip G5系统均获得美国FDA批准及欧盟CE认证，其核心优势包括：操作简化：优化器械输送系统，提升术中操控灵活性；精准定位：采用新型影像标记技术，辅助医生实现瓣膜夹合的毫米级精度；直观部署：通过改进器械释放机制，缩短学习曲线，降低手术风险。临床价值：填补高危患者治疗空白TriClip G5：针对无法耐受心脏直视手术且药物治疗无效的三尖瓣反流患者，通过股静脉入路将瓣膜小叶夹合，恢复血液单向流动。该技术避免了开胸手术创伤，为老年或合并症患者提供微创选择。MitraClip G5：用于治疗显著症状性二尖瓣反流，通过经皮介入方式减少瓣膜反流，改善心功能。此次发布距雅培TriClip系统获美国医疗保险与医疗补助服务中心（CMS）全国覆盖政策仅约一个月。CMS发布的国家承保范围确定（NCD）文件明确将TriClip经导管三尖瓣修复（T-TEER）纳入医保覆盖范围，进一步推动该技术的临床普及。雅培在心夹植入物中采用镍钛诺合金，其超弹性特性确保器械在复杂心脏解剖结构中稳定夹持瓣膜，同时减少组织损伤风险。公司强调，G5系统的设计经过大量生物力学模拟与临床验证，以保障长期耐用性。随着人口老龄化加剧，结构性心脏病发病率持续上升，微创介入技术已成为治疗趋势。雅培新一代MitraClip和TriClip G5系统的上市，不仅为临床提供了更高效的工具，也通过医保覆盖政策扩大了患者可及性。未来，随着AI技术的融合，结构性心脏病治疗有望迈向更智能化的新阶段。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2558862776","isCrawlerRequest":true}